Philadelphia Pharmaceuticals : G.A (PHIL) 2023 04 04

To: Jordan Securities Commission,

ﺔﻴﻟﺎﻤﻟﺍ ﻕﺍﺭﻭﻻﺍ ﺔﺌﻴﻫ ﺓﺩﺎﺴﻟﺍ

Amman Stock Exchange

ﻥﺎﻤﻋ ﺔﺻﺭﻮﺑ ﺓﺩﺎﺴﻟﺍ

Company's Name: PHILADELPHIA PHARMACEEUTICALS

ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ :ﺔﻛﺮﺸﻟﺍ ﻢﺳﺍ

Date: 04-04-2023 10:43:35 AM

AM 10:43:35 2023-04-04 :ﺦﻳﺭﺎﺘﻟﺍ

Subject: Invitation to Attend the Ordinary General

ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺭﻮﻀﺤﻟ ﺓﻮﻋﺩ :ﻉﻮﺿﻮﻤﻟﺍ

Assembly Meeting

The Board of Directors of PHILADELPHIA

ﺭﻮﻀﺤﻟ ﻢﻜﺗﻮﻋﺩ ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ ﺓﺭﺍﺩﺍ ﺲﻠﺠﻣ ﺮﺴﻳ

PHARMACEEUTICALS cordially invites you to attend the

-17 ﺦﻳﺭﺎﺘﺑ ﻩﺪﻘﻋ ﻱﻮﻨﻤﻟﺍ ﺔﻛﺮﺸﻠﻟ ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ

company's Ordinary General Assembly Meeting which

ﺐﺋﺮﻤﻟﺍ ﻝﺎﺼﺗﻻﺍ ﺐﺋﺎﺳﻭ ﻲﻓ 16:00 ﺔﻋﺎﺴﻟﺍ 2023-04

will be held at 16:00 on 17-04-2023 at Zoom meeting to

ﻝﺎﻤﻋﻻﺍ ﻝﻭﺪﺟ ﺔﺸﻗﺎﻨﻤﻟ ﻚﻟﺫﻭ (ﻡﻭﻭﺯ ﺞﻣﺎﻧﺮﺑ) ﻲﻧﻭﺮﺘﻜﻟﻻﺍﻭ

discuss the following matters:

:ﻲﻟﺎﺘﻟﺍ

Subject:

:ﻉﻮﺿﻮﻤﻟﺍ

Reciting and approving the minutes of the previous

ﺪﻘﻌﻨﻤﻟﺍﻭ ﻖﺑﺎﺴﻟﺍ ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺮﻀﺤﻣ ﺓﺀﺍﺮﻗ

ordinary meeting of the General Assembly which was

ﻪﻴﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍﻭ 2022-04-27 ﺦﻳﺭﺎﺘﺑ

held on 27-04-2022

The Report of the Board of Directors on the activities of

ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ ﻝﺎﻤﻋﺍ ﻦﻋ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺮﻳﺮﻘﺗ

the Company during the year 31-12-2022 along with its

ﺔﻛﺮﺸﻠﻟ ﺔﻴﻠﺒﻘﺘﺴﻤﻟﺍ ﺔﻄﺨﻟﺍﻭ 2022-12-31 ﻲﻓ

future plans

The Report of the Company's auditors on its financial

ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ ﻝﻮﺣ ﺕﺎﺑﺎﺴﺤﻟﺍ ﻲﻘﻗﺪﻣ ﺮﻳﺮﻘﺗ

statements for the year ended 31-12-2022

2022-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ

The financial statements for the year ended 31-12-2022

2022-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ

Specifying the profits that the Board of Directors proposes

ﻰﻠﻋ ﺎﻬﻌﻳﺯﻮﺗ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺡﺮﺘﻘﻳ ﻲﺘﻟﺍ ﺡﺎﺑﺭﻷﺍ ﺔﺒﺴﻧ ﺪﻳﺪﺤﺗ

to distribute and specifying the reserves and allocations'

ﺎﻬﻴﻠﻋ ﺺﻧ ﻲﺘﻟﺍ ﺕﺎﺼﺼﺨﻤﻟﺍﻭ ﺕﺎﻃﺎﻴﺘﺣﻻﺍ ﺪﻳﺪﺤﺗﻭ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ

which the Law and the Company's Memorandum of

ﺎﻬﻋﺎﻄﺘﻗﺍ ﻰﻠﻋ ﺔﻛﺮﺸﻟﺍ ﻡﺎﻈﻧﻭ ﻥﻮﻧﺎﻘﻟﺍ

Association stipulate its deduction

ﻰﻠﻋ ﺔﻳﺪﻘﻧ ﺡﺎﺑﺭﺃ ﻊﻳﺯﻮﺗ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺎﺑ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻠﻟ ﺔﻴﺻﻮﺘﻟﺍ

ﻰﻠﻋ ﺔﻳﺪﻘﻧ ﺡﺎﺑﺭﺃ ﻊﻳﺯﻮﺗ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺎﺑ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻠﻟ ﺔﻴﺻﻮﺘﻟﺍ

450,000 ﻊﻗﺍﻮﺑﻭ ﺔﻛﺮﺸﻟﺍ ﻝﺎﻣ ﺱﺃﺭ ﻦﻣ %6 ﺔﺒﺴﻨﺑ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ

450,000 ﻊﻗﺍﻮﺑﻭ ﺔﻛﺮﺸﻟﺍ ﻝﺎﻣ ﺱﺃﺭ ﻦﻣ %6 ﺔﺒﺴﻨﺑ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ

ﺭﺎﻨﻳﺩ.

.ﺭﺎﻨﻳﺩ

Discharging the Board's members from their liabilities in

ﻢﻬﺗﺎﻓﺮﺼﺗ ﻦﻋ ﺔﻴﻟﻭﺆﺴﻤﻟﺍ ﻦﻣ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺀﺎﻀﻋﺃ ﺔﻣﺫ ﺀﺍﺮﺑﺍ

respect of the financial year ended 31-12-2022

2022-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻨﺴﻟﺍ ﻝﻼﺧ

Electing the Company's auditors for the next fiscal year,

ﺪﻳﺪﺤﺗﻭ ﺔﻠﺒﻘﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﺏﺎﺨﺘﻧﺍ

and deciding on their remunerations or authorizing the

ﺎﻫﺪﻳﺪﺤﺘﺑ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺾﻳﻮﻔﺗ ﻭﺍ ﻢﻬﺑﺎﻌﺗﺃ

Board of Directors to determine such remunerations

Any other matters which the General Assembly proposes to

ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻲﻓ ﺎﻬﺟﺍﺭﺩﺇ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﺡﺮﺘﻘﺗ ﻯﺮﺧﺃ ﺭﻮﻣﺃ ﻱﺃ

include in the agenda, and are within the work scope of the

ﻥﺃ ﻰﻠﻋ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻠﻟ ﻱﺩﺎﻌﻟﺍ ﻉﺎﻤﺘﺟﻻﺍ ﻝﺎﻤﻋﺃ ﻕﺎﻄﻧ ﻲﻓ ﻞﺧﺪﻳﻭ

General Assembly in its ordinary meeting, provided that

ﻦﻣ ﺩﺪﻋ ﺔﻘﻓﺍﻮﻤﺑ ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻲﻓ ﺡﺍﺮﺘﻗﻻﺍ ﺍﺬﻫ ﺝﺍﺭﺩﺃ ﻥﺮﺘﻘﻳ

such a proposal is approved by shareholders representing

ﻲﻓ ﺔﻠﺜﻤﻤﻟﺍ ﻢﻬﺳﻷﺍ ﻦﻣ (%10) ﻦﻋ ﻞﻘﻳ ﻻ ﺎﻣ ﻥﻮﻠﺜﻤﻳ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ

not less than 10% of the shares represented in the meeting

ﻉﺎﻤﺘﺟﻻﺍ

ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻰﻠﻋ ﺎﻬﺟﺍﺭﺩﺇ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﺡﺮﺘﻘﺗ ﻯﺮﺧﺃ ﺭﻮﻣﺃ ﺔﻳﺍ

ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻰﻠﻋ ﺎﻬﺟﺍﺭﺩﺇ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﺡﺮﺘﻘﺗ ﻯﺮﺧﺃ ﺭﻮﻣﺃ ﺔﻳﺍ

ﻲﻓ ﻞﺧﺪﻳ ﺎﻤﻣ ﺕﺎﻛﺮﺸﻟﺍ ﻥﻮﻧﺎﻗ ﻦﻣ (171) ﺓﺩﺎﻤﻟﺍ ﻡﺎﻜﺣﺃ ﺐﺴﺣ

ﻲﻓ ﻞﺧﺪﻳ ﺎﻤﻣ ﺕﺎﻛﺮﺸﻟﺍ ﻥﻮﻧﺎﻗ ﻦﻣ (171) ﺓﺩﺎﻤﻟﺍ ﻡﺎﻜﺣﺃ ﺐﺴﺣ

ﺡﺍﺮﺘﻗﻻﺍ ﺍﺬﻫ ﻥﺮﺘﻘﻳ ﻥﺃ ﻰﻠﻋ ،ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻠﻟ ﻱﺩﺎﻌﻟﺍ ﻉﺎﻤﺘﺟﻻﺍ ﻕﺎﻄﻧ

ﺡﺍﺮﺘﻗﻻﺍ ﺍﺬﻫ ﻥﺮﺘﻘﻳ ﻥﺃ ﻰﻠﻋ ،ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻠﻟ ﻱﺩﺎﻌﻟﺍ ﻉﺎﻤﺘﺟﻻﺍ ﻕﺎﻄﻧ

ﻦﻣ %10 ﻦﻋ ﻞﻘﻳ ﻻ ﺎﻣ ﻥﻮﻠﺜﻤﻳ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ ﻦﻣ ﺩﺪﻋ ﺔﻘﻓﺍﻮﻤﺑ

ﻦﻣ %10 ﻦﻋ ﻞﻘﻳ ﻻ ﺎﻣ ﻥﻮﻠﺜﻤﻳ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ ﻦﻣ ﺩﺪﻋ ﺔﻘﻓﺍﻮﻤﺑ

ﻉﺎﻤﺘﺟﻻﺍ ﻲﻓ ﺔﻠﺜﻤﻤﻟﺍ ﻢﻬﺳﻷﺍ.

.ﻉﺎﻤﺘﺟﻻﺍ ﻲﻓ ﺔﻠﺜﻤﻤﻟﺍ ﻢﻬﺳﻷﺍ

Please accept our sincere thanks and appreciation.

.ﻡﺍﺮﺘﺣﻻﺍ ﻖﺋﺎﻓ ﻝﻮﺒﻘﺑ ﺍﻮﻠﻀﻔﺗﻭ

Chairman of Board of Directors

ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺲﻴﺋﺭ

User Name: Belal Salameh

Belal Salameh :ﻡﺪﺨﺘﺴﻤﻟﺍ ﻢﺳﺍ